source
- STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6BGSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of biopharma acquisitions.STAT · 1mo ago↗ source
- Alcohol study discarded by Trump officials is published in scientific journalA government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light drinking.STAT · 1mo ago↗ source
- Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or restHealth workers at the epicenter of Congo's Ebola outbreak are laboring with little pay or rest.STAT · 1mo ago↗ source